Loading clinical trials...
Loading clinical trials...
A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.
Conditions
Interventions
S42909 100 mg
S42909 200 mg
+4 more
Locations
80
United States
ILD Research Center
Carlsbad, California, United States
Center for Clinical Research Inc.
Carmichael, California, United States
Center for Clinical Research Inc.
Castro Valley, California, United States
Limb Preservation Platform, Inc.
Fresno, California, United States
Foot and Ankle Clinic
Los Angeles, California, United States
Stanford Hospitals and Clinics
Redwood City, California, United States
Start Date
September 12, 2017
Primary Completion Date
December 12, 2019
Completion Date
January 22, 2020
Last Updated
October 8, 2020
NCT06811909
NCT05489588
NCT06606210
NCT06544564
NCT05549609
NCT04737941
Lead Sponsor
Ilkos Therapeutic Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions